Sign up
OCS

Oculis Holding AG Ordinary shares (NASDAQ: OCS)

Healthcare · Biotechnology

$7.39−0.12 (−1.60%)

Last close · Nov 18, 2026 · NASDAQ USD

Set alert

The Quantellect read. OCS fell 1.60% in the Nov 18 session to $7.39, which is 77.4% below its 52-week high of $32.65. Short interest is 3.07% of float with a 2.61% borrow fee. Seven active firms cover the stock as of Nov 19, 2026; six active firms with targets average $36.67 over 12 months. Descriptive summary of the data on this page, not a recommendation.

Relative valuationHigher multiples than peers

P/S 433.7× vs peer median 13.9×

MomentumNeutral

RSI (14) 44.3 (overbought above 70, oversold below 30) · as of Nov 18, 2026

TrendBelow both averages

$7.39 vs $8.48 and $17.55 · as of Nov 18, 2026

Short interest3.1% of float

FINRA settlement Oct 30, 2026

OCS price chart

Price $7.39 · As of Nov 18, 2026, 3:59 PM ET

Open full chart →
Nov 18, 2026O $7.56H $7.75L $7.20C $7.39Vol 312K

Chart loads when this section enters view.

Text price and event history
6M plotted price range (ET)
Range6M
First dateMay 18, 2026 ET
Last dateNov 18, 2026 ET
Open$30.70
High$31.27
Low$6.78
Close$7.39
Volume59,419,096
Plotted bars129

Plotted OHLCV bars

  1. May 18, 2026 ET · Open $30.70 · High $30.70 · Low $27.77 · Close $28.07 · Volume 395,605
  2. May 19, 2026 ET · Open $28.20 · High $29.38 · Low $27.69 · Close $27.96 · Volume 290,490
  3. May 20, 2026 ET · Open $27.89 · High $28.25 · Low $27.35 · Close $27.91 · Volume 428,530
  4. May 21, 2026 ET · Open $29.00 · High $31.05 · Low $28.51 · Close $31.00 · Volume 966,091
  5. May 22, 2026 ET · Open $31.27 · High $31.27 · Low $29.16 · Close $29.49 · Volume 487,736
  6. May 26, 2026 ET · Open $29.65 · High $30.25 · Low $29.11 · Close $29.93 · Volume 273,596
  7. May 27, 2026 ET · Open $29.93 · High $30.69 · Low $29.50 · Close $29.61 · Volume 297,477
  8. May 28, 2026 ET · Open $29.66 · High $29.98 · Low $28.99 · Close $29.65 · Volume 307,418
  9. May 29, 2026 ET · Open $29.30 · High $29.65 · Low $20.01 · Close $22.71 · Volume 2,856,633
  10. Jun 1, 2026 ET · Open $15.78 · High $16.00 · Low $13.81 · Close $14.51 · Volume 6,679,658
  11. Jun 2, 2026 ET · Open $13.88 · High $14.00 · Low $12.26 · Close $12.29 · Volume 3,111,079
  12. Jun 3, 2026 ET · Open $11.70 · High $13.43 · Low $11.70 · Close $13.14 · Volume 1,682,168
  13. Jun 4, 2026 ET · Open $12.98 · High $13.00 · Low $11.31 · Close $11.83 · Volume 1,345,748
  14. Jun 5, 2026 ET · Open $11.67 · High $12.05 · Low $11.17 · Close $11.21 · Volume 871,780
  15. Jun 8, 2026 ET · Open $11.20 · High $11.46 · Low $10.52 · Close $10.71 · Volume 1,468,648
  16. Jun 9, 2026 ET · Open $10.97 · High $11.77 · Low $10.65 · Close $10.98 · Volume 1,426,127
  17. Jun 10, 2026 ET · Open $10.90 · High $11.60 · Low $10.86 · Close $10.97 · Volume 644,747
  18. Jun 11, 2026 ET · Open $10.92 · High $11.33 · Low $10.81 · Close $11.00 · Volume 428,137
  19. Jun 12, 2026 ET · Open $11.01 · High $11.55 · Low $10.91 · Close $11.09 · Volume 406,882
  20. Jun 15, 2026 ET · Open $11.50 · High $11.67 · Low $11.06 · Close $11.61 · Volume 760,046
  21. Jun 16, 2026 ET · Open $11.59 · High $11.65 · Low $11.10 · Close $11.45 · Volume 615,721
  22. Jun 17, 2026 ET · Open $11.38 · High $11.67 · Low $11.20 · Close $11.30 · Volume 581,063
  23. Jun 18, 2026 ET · Open $11.60 · High $11.77 · Low $10.88 · Close $11.22 · Volume 772,599
  24. Jun 22, 2026 ET · Open $11.35 · High $11.88 · Low $11.20 · Close $11.67 · Volume 480,711
  25. Jun 23, 2026 ET · Open $11.41 · High $12.17 · Low $11.36 · Close $11.72 · Volume 841,925
  26. Jun 24, 2026 ET · Open $11.70 · High $11.76 · Low $11.44 · Close $11.56 · Volume 383,831
  27. Jun 25, 2026 ET · Open $11.56 · High $12.01 · Low $11.50 · Close $11.74 · Volume 537,895
  28. Jun 26, 2026 ET · Open $11.69 · High $12.01 · Low $11.57 · Close $12.00 · Volume 374,879
  29. Jun 29, 2026 ET · Open $12.04 · High $13.15 · Low $11.87 · Close $13.09 · Volume 661,669
  30. Jun 30, 2026 ET · Open $13.05 · High $13.89 · Low $12.82 · Close $13.87 · Volume 633,588
  31. Jul 1, 2026 ET · Open $13.84 · High $13.91 · Low $13.40 · Close $13.53 · Volume 451,464
  32. Jul 2, 2026 ET · Open $13.72 · High $14.34 · Low $13.55 · Close $14.12 · Volume 398,419
  33. Jul 6, 2026 ET · Open $14.20 · High $14.35 · Low $13.53 · Close $13.80 · Volume 379,127
  34. Jul 7, 2026 ET · Open $13.84 · High $13.84 · Low $13.02 · Close $13.56 · Volume 505,345
  35. Jul 8, 2026 ET · Open $13.59 · High $13.94 · Low $12.92 · Close $13.70 · Volume 521,377
  36. Jul 9, 2026 ET · Open $13.68 · High $14.00 · Low $13.24 · Close $13.70 · Volume 524,767
  37. Jul 10, 2026 ET · Open $13.70 · High $13.79 · Low $13.27 · Close $13.63 · Volume 201,545
  38. Jul 13, 2026 ET · Open $13.42 · High $13.63 · Low $12.88 · Close $13.15 · Volume 302,553
  39. Jul 14, 2026 ET · Open $13.16 · High $13.48 · Low $12.89 · Close $12.93 · Volume 312,409
  40. Jul 15, 2026 ET · Open $12.84 · High $13.22 · Low $12.60 · Close $13.12 · Volume 236,801
  41. Jul 16, 2026 ET · Open $12.97 · High $13.21 · Low $12.32 · Close $12.61 · Volume 296,580
  42. Jul 17, 2026 ET · Open $12.43 · High $12.76 · Low $12.11 · Close $12.19 · Volume 304,143
  43. Jul 20, 2026 ET · Open $12.24 · High $12.70 · Low $11.65 · Close $11.73 · Volume 258,780
  44. Jul 21, 2026 ET · Open $11.79 · High $11.96 · Low $11.62 · Close $11.96 · Volume 327,396
  45. Jul 22, 2026 ET · Open $11.79 · High $11.98 · Low $11.36 · Close $11.43 · Volume 293,100
  46. Jul 23, 2026 ET · Open $11.44 · High $11.65 · Low $11.23 · Close $11.44 · Volume 240,335
  47. Jul 24, 2026 ET · Open $11.47 · High $11.47 · Low $10.93 · Close $11.13 · Volume 375,472
  48. Jul 27, 2026 ET · Open $11.20 · High $11.59 · Low $10.88 · Close $11.02 · Volume 379,542
  49. Jul 28, 2026 ET · Open $10.82 · High $11.39 · Low $10.75 · Close $11.06 · Volume 435,869
  50. Jul 29, 2026 ET · Open $11.06 · High $11.29 · Low $10.79 · Close $10.84 · Volume 196,023
  51. Jul 30, 2026 ET · Open $10.84 · High $11.51 · Low $10.73 · Close $11.21 · Volume 474,671
  52. Jul 31, 2026 ET · Open $11.34 · High $11.35 · Low $10.87 · Close $11.31 · Volume 204,885
  53. Aug 3, 2026 ET · Open $11.95 · High $12.15 · Low $11.67 · Close $11.89 · Volume 295,726
  54. Aug 4, 2026 ET · Open $12.07 · High $12.36 · Low $11.89 · Close $11.99 · Volume 310,994
  55. Aug 5, 2026 ET · Open $12.10 · High $12.42 · Low $11.87 · Close $12.07 · Volume 579,286
  56. Aug 6, 2026 ET · Open $11.96 · High $12.51 · Low $11.82 · Close $12.38 · Volume 264,919
  57. Aug 7, 2026 ET · Open $12.95 · High $13.28 · Low $12.41 · Close $12.68 · Volume 370,878
  58. Aug 10, 2026 ET · Open $12.31 · High $12.90 · Low $12.31 · Close $12.76 · Volume 287,343
  59. Aug 11, 2026 ET · Open $12.85 · High $12.90 · Low $12.51 · Close $12.75 · Volume 143,125
  60. Aug 12, 2026 ET · Open $12.91 · High $13.25 · Low $12.83 · Close $12.89 · Volume 253,152
  61. Aug 13, 2026 ET · Open $12.87 · High $13.19 · Low $12.64 · Close $12.82 · Volume 193,265
  62. Aug 14, 2026 ET · Open $12.84 · High $13.09 · Low $12.52 · Close $12.94 · Volume 125,379
  63. Aug 17, 2026 ET · Open $12.86 · High $13.34 · Low $12.80 · Close $13.14 · Volume 220,313
  64. Aug 18, 2026 ET · Open $13.07 · High $13.20 · Low $12.89 · Close $13.19 · Volume 198,865
  65. Aug 19, 2026 ET · Open $13.21 · High $13.70 · Low $13.15 · Close $13.57 · Volume 272,419
  66. Aug 20, 2026 ET · Open $13.41 · High $13.54 · Low $13.04 · Close $13.14 · Volume 111,216
  67. Aug 21, 2026 ET · Open $13.17 · High $13.27 · Low $13.00 · Close $13.09 · Volume 76,462
  68. Aug 24, 2026 ET · Open $13.10 · High $13.25 · Low $12.87 · Close $13.18 · Volume 150,387
  69. Aug 25, 2026 ET · Open $13.25 · High $13.42 · Low $12.90 · Close $12.96 · Volume 192,367
  70. Aug 26, 2026 ET · Open $12.98 · High $13.06 · Low $12.81 · Close $12.97 · Volume 161,922
  71. Aug 27, 2026 ET · Open $12.88 · High $13.12 · Low $12.42 · Close $12.43 · Volume 111,445
  72. Aug 28, 2026 ET · Open $12.38 · High $12.50 · Low $12.14 · Close $12.21 · Volume 221,869
  73. Aug 31, 2026 ET · Open $12.11 · High $12.34 · Low $11.99 · Close $12.25 · Volume 114,052
  74. Sep 1, 2026 ET · Open $12.17 · High $12.29 · Low $12.02 · Close $12.18 · Volume 83,362
  75. Sep 2, 2026 ET · Open $12.20 · High $12.40 · Low $11.95 · Close $12.02 · Volume 183,087
  76. Sep 3, 2026 ET · Open $12.10 · High $12.29 · Low $11.96 · Close $12.17 · Volume 179,233
  77. Sep 4, 2026 ET · Open $12.07 · High $12.66 · Low $11.93 · Close $12.17 · Volume 124,347
  78. Sep 8, 2026 ET · Open $12.09 · High $12.24 · Low $11.93 · Close $12.16 · Volume 138,632
  79. Sep 9, 2026 ET · Open $12.11 · High $12.13 · Low $11.40 · Close $11.47 · Volume 164,455
  80. Sep 10, 2026 ET · Open $11.34 · High $11.60 · Low $11.00 · Close $11.31 · Volume 169,325
  81. Sep 11, 2026 ET · Open $11.39 · High $11.98 · Low $10.50 · Close $10.56 · Volume 226,616
  82. Sep 14, 2026 ET · Open $10.56 · High $10.84 · Low $10.51 · Close $10.60 · Volume 153,188
  83. Sep 15, 2026 ET · Open $10.60 · High $10.61 · Low $10.00 · Close $10.07 · Volume 159,306
  84. Sep 16, 2026 ET · Open $10.11 · High $10.20 · Low $9.65 · Close $9.91 · Volume 314,098
  85. Sep 17, 2026 ET · Open $9.90 · High $10.16 · Low $9.85 · Close $9.98 · Volume 248,055
  86. Sep 18, 2026 ET · Open $10.17 · High $10.43 · Low $9.67 · Close $10.14 · Volume 412,068
  87. Sep 21, 2026 ET · Open $10.19 · High $10.35 · Low $10.00 · Close $10.14 · Volume 201,825
  88. Sep 22, 2026 ET · Open $10.27 · High $10.84 · Low $10.26 · Close $10.71 · Volume 206,769
  89. Sep 23, 2026 ET · Open $10.64 · High $10.77 · Low $9.88 · Close $9.99 · Volume 143,773
  90. Sep 24, 2026 ET · Open $9.94 · High $9.95 · Low $9.21 · Close $9.41 · Volume 209,251
  91. Sep 25, 2026 ET · Open $9.71 · High $9.71 · Low $9.10 · Close $9.27 · Volume 239,611
  92. Sep 28, 2026 ET · Open $9.20 · High $9.33 · Low $9.00 · Close $9.06 · Volume 266,991
  93. Sep 29, 2026 ET · Open $9.10 · High $9.38 · Low $9.07 · Close $9.13 · Volume 373,456
  94. Sep 30, 2026 ET · Open $9.20 · High $9.48 · Low $9.02 · Close $9.34 · Volume 434,739
  95. Oct 1, 2026 ET · Open $9.16 · High $9.26 · Low $8.67 · Close $8.76 · Volume 578,446
  96. Oct 2, 2026 ET · Open $8.82 · High $8.83 · Low $8.53 · Close $8.73 · Volume 586,303
  97. Oct 5, 2026 ET · Open $8.79 · High $9.00 · Low $8.56 · Close $8.56 · Volume 242,001
  98. Oct 6, 2026 ET · Open $8.61 · High $8.80 · Low $8.30 · Close $8.72 · Volume 291,649
  99. Oct 7, 2026 ET · Open $8.83 · High $8.83 · Low $8.35 · Close $8.50 · Volume 173,693
  100. Oct 8, 2026 ET · Open $8.50 · High $8.75 · Low $8.37 · Close $8.66 · Volume 452,012
  101. Oct 9, 2026 ET · Open $8.60 · High $8.75 · Low $8.30 · Close $8.34 · Volume 162,060
  102. Oct 12, 2026 ET · Open $8.27 · High $8.33 · Low $7.85 · Close $7.88 · Volume 283,960
  103. Oct 13, 2026 ET · Open $7.84 · High $7.84 · Low $7.32 · Close $7.62 · Volume 320,225
  104. Oct 14, 2026 ET · Open $7.51 · High $7.74 · Low $7.11 · Close $7.17 · Volume 517,709
  105. Oct 15, 2026 ET · Open $7.25 · High $7.60 · Low $7.15 · Close $7.40 · Volume 559,213
  106. Oct 16, 2026 ET · Open $7.33 · High $7.46 · Low $7.16 · Close $7.29 · Volume 293,702
  107. Oct 19, 2026 ET · Open $7.25 · High $7.46 · Low $7.15 · Close $7.32 · Volume 288,389
  108. Oct 20, 2026 ET · Open $7.29 · High $7.79 · Low $7.29 · Close $7.49 · Volume 318,680
  109. Oct 21, 2026 ET · Open $7.54 · High $8.02 · Low $7.40 · Close $7.87 · Volume 324,101
  110. Oct 22, 2026 ET · Open $7.77 · High $8.31 · Low $7.73 · Close $8.09 · Volume 427,887
  111. Oct 23, 2026 ET · Open $8.04 · High $8.07 · Low $7.82 · Close $7.90 · Volume 294,727
  112. Oct 26, 2026 ET · Open $7.88 · High $8.03 · Low $7.65 · Close $7.96 · Volume 206,966
  113. Oct 27, 2026 ET · Open $7.92 · High $8.15 · Low $7.68 · Close $7.83 · Volume 189,294
  114. Oct 28, 2026 ET · Open $7.80 · High $8.05 · Low $7.72 · Close $7.98 · Volume 220,031
  115. Oct 29, 2026 ET · Open $8.09 · High $8.53 · Low $8.09 · Close $8.24 · Volume 263,729
  116. Oct 30, 2026 ET · Open $8.19 · High $8.84 · Low $8.19 · Close $8.26 · Volume 309,703
  117. Nov 2, 2026 ET · Open $8.38 · High $8.54 · Low $7.66 · Close $7.71 · Volume 246,352
  118. Nov 3, 2026 ET · Open $7.72 · High $7.87 · Low $7.29 · Close $7.63 · Volume 541,789
  119. Nov 4, 2026 ET · Open $7.60 · High $7.89 · Low $6.80 · Close $7.28 · Volume 550,216
  120. Nov 5, 2026 ET · Open $7.30 · High $7.85 · Low $6.78 · Close $6.83 · Volume 371,648
  121. Nov 6, 2026 ET · Open $6.83 · High $7.64 · Low $6.81 · Close $7.49 · Volume 404,086
  122. Nov 9, 2026 ET · Open $7.67 · High $8.04 · Low $7.49 · Close $7.76 · Volume 339,857
  123. Nov 10, 2026 ET · Open $7.72 · High $8.04 · Low $7.54 · Close $7.59 · Volume 266,851
  124. Nov 11, 2026 ET · Open $7.67 · High $8.03 · Low $7.60 · Close $7.61 · Volume 227,360
  125. Nov 12, 2026 ET · Open $7.60 · High $7.86 · Low $7.33 · Close $7.50 · Volume 299,110
  126. Nov 13, 2026 ET · Open $7.51 · High $7.68 · Low $7.28 · Close $7.64 · Volume 183,977
  127. Nov 16, 2026 ET · Open $7.97 · High $8.21 · Low $7.54 · Close $7.63 · Volume 211,165
  128. Nov 17, 2026 ET · Open $7.76 · High $7.82 · Low $7.09 · Close $7.51 · Volume 239,990
  129. Nov 18, 2026 ET · Open $7.56 · High $7.75 · Low $7.20 · Close $7.39 · Volume 311,564

Event records

Event records load after the price chart.

Split-adjusted daily prices · Price as of Nov 18, 2026, 8:44 PM ET

Initial 6M price range summary
Range6M
First close$28.07
Last close$7.39
High$31.27
Low$6.78
Volume59,419,096
Open
$7.56Nov 18, 2026 session
Previous close
$7.51Nov 17, 2026 close
Day range
$7.20 – $7.75Nov 18, 2026 session
52-week range
$6.83 – $32.65Through Nov 18, 2026
Volume
311.60KNov 18, 2026 session
Average volume (30 calendar days, 22 sessions)
306.78KThrough Nov 18, 2026
Market cap$508.72M
P/E (TTM)63.6
Forward P/E—
EPS (TTM)stale vendor snapshot —
Dividend yielddata unavailable —
Beta (5-year monthly vs SPY)—

Price history

OCS · NASDAQ · USD

Split-adjusted · volume in shares

Price history unavailable

Notable price movement

Sessions where the close moved at least twice its average daily move of the prior 20 sessions (minimum 3%), or 10% or more.

  1. $7.49+9.66%

    Trading volume was 1.2 times the 30-day average, with 404.09K shares traded.

  2. $6.83−6.18%

    Trading volume was 1.1 times the 30-day average, with 371.65K shares traded.

  3. $7.71−6.66%

    Trading volume was 0.8 times the 30-day average, with 246.35K shares traded.

Options flow

— · Options flow not available

Q Score

— · Q Score not available

Quantellect signals

Change since Nov 18

Insufficient data · Tide session Nov 18, 2026

Tide43Calm Tide—
Squeeze34Watch—
How the scores work →

How OCS compares with its industry

Against 592 other US-listed Biotechnology stocks

Dot = rank among peers, low to high · tick = peer median · colour marks the top and bottom 10%

Strongest points

  1. Latest-quarter year-over-year sales growth was 18.8%, higher than 77% of 592 peers.Peer median 0.0% · As of Nov 17, 2026

Points of caution

  1. Six-month return was -73.5%, with only 10% of 545 peers reporting a lower value.Peer median −26.6% · As of Nov 17, 2026
  2. Trailing-year net margin was 0%, with only 19% of 583 peers reporting a lower value.Peer median 0.0% · As of Nov 17, 2026

Valuation

Higher multiples than peers

  • Price/sales433.69×13.85×

    Higher than 89% of 407 peers

  • Forward P/E—14.90×

    Not ranked: only 194 of 592 peers report it

  • Price/book1.93×2.58×

    Higher than 40% of 551 peers

Profitability

Profitability metrics are mixed versus peers.

  • Gross margin—78.4%

    Not ranked: only 247 of 592 peers report it

  • Operating margin—0.0%

    Not ranked: only 443 of 592 peers report it

  • Net margin0.0%0.0%

    Higher than 19% of 583 peers

  • Return on equity−43.7%−68.0%

    Higher than 67% of 554 peers

Growth

Growth metrics are higher than most peers.

  • Quarterly sales growth, year over year18.8%0.0%

    Higher than 77% of 592 peers

  • 5-year sales growth rate—11.3%

    Not ranked: only 140 of 592 peers report it

Balance sheet

Not enough peers report balance sheet metrics for a group comparison.

  • Current ratio—5.01

    Not ranked: only 499 of 592 peers report it

  • Debt/equity (total borrowings)—0.23

    Not ranked: only 117 of 592 peers report it

Momentum

Returns are lower than most peers.

  • 1-year return−61.4%−28.3%

    Higher than 26% of 522 peers

  • 6-month return−73.5%−26.6%
    Bottom 10% of peers

    Higher than 10% of 545 peers

  • 3-month return−43.8%−29.4%

    Higher than 31% of 558 peers

Compared with 592 other US-listed Biotechnology stocks · fundamentals as of Nov 1, 2026 · prices as of Nov 13, 2026

Upcoming events

— · Upcoming events not available

Analyst consensus

Buy

0Strong Buy
7Buy
0Neutral
0Sell
0Strong Sell

Based on 7 active firms as of Nov 19, 2026 (365-day activity window)

12-month price targets (third-party analysts)

Low$20.00
Average$36.67
High$45.00

As of Nov 19, 2026 across 6 active firms with targets. Targets are published by third-party analysts, not by Quantellect.

Full analyst forecast →

Earnings history

— · Earnings history not available

Smart-money activity

In the last 60 days: 0 insider sales and 0 purchases. Last quarter: 0 new 13F positions. No congressional trades in 90 days.

DateTypeWhoActionAmountSource
13FPoint72 Asset Management, L.P.Opened position$1.5M13F filing
13FCITADEL ADVISORS LLCReduced position$4.3M13F filing
13FMILLENNIUM MANAGEMENT LLCIncreased position$24.3M13F filing
13FTWO SIGMA INVESTMENTS, LPClosed position$013F filing
13FRENAISSANCE TECHNOLOGIES LLCClosed position$013F filing
13FCITADEL ADVISORS LLCOpened position$3.3M13F filing
13FMILLENNIUM MANAGEMENT LLCOpened position$312.4K13F filing
13FTWO SIGMA INVESTMENTS, LPOpened position$488.1K13F filing
13FRENAISSANCE TECHNOLOGIES LLCOpened position$499.3K13F filing
13FPOLEN CAPITAL MANAGEMENT LLCClosed position$013F filing
All smart-money activity →

News and press releases

All OCS news →

Company profile

Oculis Holding AG, a clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic, neuro-ophthalmic, and neurological diseases in Switzerland and internationally. The company's lead product candidate is OCS-01, a topical dexamethasone optireach formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b clinical trials for the treatment for dry eye disease; and OCS-05, a disease

CEO
Dr. Riad Sherif M.B.A., M.D.
Headquarters
Zug, Switzerland
Employees
60
IPO date
Mar 2, 2023
Sector
Healthcare
Industry
Biotechnology
Website
oculis.com

Data sources: exchange quotes delayed 15 minutes, FINRA short interest, SEC filings, OPRA options data and third-party analyst data. Education only. Nothing on this page is a recommendation to buy or sell a security.